Management of the Unknown Primary in Patients with Metastatic Cancer of the Head and Neck

Abstract

The evaluation of the patient with metastatic cervical lymph node squamous cell carcinoma and an unknown primary tumor frequently involves the use of guided biopsies as a diagnostic tool. This study was performed to assess the effectiveness of these biopsies. Using a retrospective chart review, we identified 25 patients who had undergone a total of 100 guided biopsies to evaluate an unknown primary malignancy of the head and neck. We found that 99 of the 100 biopsies were negative for malignancy. Although guided biopsies were obviously not helpful in these cases, we believe this might be attributable to the fact that the method of performing them is inconsistent among surgeons. Therefore, we present an algorithm for the management of the unknown primary head and neck malignancy, including recommendations regarding the use of guided biopsies.

References

Martin

, Romieu

The diagnostic significance of a “lump in the neck.”

Postgrad Med 1952;11:491–500.

Winegar

, Griffin

The occult primary tumor. Arch Otolaryngol 1973;98:159–63.

McGuirt

. The unknown primary in metastatic head and neck cancer, a clinical approach. N C Med J 1978;39:299–300.

Martin

, Morfit

. Cervical lymph node metastasis as the first symptom of cancer. Surg Gynecol Obstet 1944;78:133–59.

Coker

, Casterline

, Chambers

, Jaques

. Metastases to lymph nodes of the head and neck from an unknown primary site. Am J Surg 1977;134:517–22.

Fried

, Diehl

Jr. , Brownson

, Cervical metastasis from an unknown primary. Ann Otol Rhinol Laryngol 1975;84:152–7.

MacComb

. Diagnosis and treatment of metastatic cervical cancerous nodes from an unknown primary site. Am J Surg 1972;124:441–9.

Gluckman

. Hematoporphyrin photodynamic therapy: Is there truly a future in head and neck oncology? Reflections on a 5-year experience. Laryngoscope 1991;101:36–42.

Lore

. An Atlas of Head and Neck Surgery. 3rd ed. Philadelphia: W.B. Saunders, 1988.

10.

Marchetta

, Sako

, Camp

Multiple malignancies in patients with head and neck cancer. Am J Surg 1965;110:537–41.

11.

Epstein

, Scully

, Spinelli

Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992;21:160–3.

12.

Caspersson

, Santesson

Studies on protein metabolism in the cells of epithelial tumors. Acta Radiol 1942;46:17–8.

13.

Richart

. A clinical test for the in vivo delineation of dysplasia and carcinoma in situ. Am J Obstet Gynecol 1963;86:703–12.

14.

Mashberg

, Samit

Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 1995;45:328–51.

15.

Warnakulasuriya

, Johnson

. Sensitivity and specificity of OraScan® toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 1996;25:97–103.

16.

McGuirt

. Differential diagnosis of neck masses. In: Cummings

, Schuller

, eds. Otolaryngology–Head and Neck Surgery. Vol. 2, 2nd ed. St. Louis: Mosby-Year Book, 1993.

17.

Righi

, Sofferman

. Screening unilateral tonsillectomy in the unknown primary. Laryngoscope 1995;105:548–50.

18.

Thawley

, O'Leary

Malignant neoplasms of the oropharynx. In: Cummings

, Schuller

, eds. Otolaryngology–Head and Neck Surgery. Vol. 2, 2nd ed. St. Louis: Mosby-Year Book, 1993.

19.

Mendenhall

, Million

, Bova

. Analysis of time-dose factors in clinically positive neck nodes treated with irradiation alone in squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1984;10:639–43.